Population Study

Predictive Models

GeneHarmonics Inc. is helping to develop population-based studies that can help collect data points to better understand infectious diseases that can hopefully be used to develop predictive models to fight them.

The pilot will be designed around studies for Malaria – considered the number one killer in the world. The importance of this project cannot be understated. For the first time, a multi-sectoral initiative shall be deploying the convergence of 3 technologies – Quantum Dots bio-diagnostics, Secured Data Systems, and Drug Delivery Systems. The groups who signed up to participate in the project includes: (a) the Asian office representing a global company with presence in more than 72 countries, (2) one of the leading world experts in the field of entomology and eco-toxicology, (3) an Asia-based non-profit organization who specializes in operationalizing community-based projects and who has affiliations with international organizations with a combined presence in more than 100 countries. (4) US scientists, and (5) Organizations who have been working on the eradication of Malaria in Africa.

The population study shall create a working model based on the following targeted milestones: the collection of diagnostics data from a large number of people in a community to study trends of Malaria-associated biomarkers in individuals; Develop and launch a secured data platform that anonymize data and integrate the same to IOT sensors.

Challenges We Can Overcome

There are several challenges the we are looking to overcome simply by the composition of our team, the depth of our technologies, and the strength of our strategic partners. Our Quantum Dot diagnostic devices are portable, rapid and quantitative making it deployable to populations that are being studied – the diagnostics can be arranged to come to community centers and/or even houses. Rapid, quantitative and portable means getting the whole population tested including those that are asymptomatic persons who are, unknowingly, vectors of the pathogens themselves.  The data platform will give us insights on how aggregated and filtered information can be used to track the movement of pathogens within a large community. AADC has been organizing community-based projects for more than 20 years – at times in partnership with the likes of CARE Org (present in 100 countries) and OXFAM (present in several countries as well. The professional services that ManpowerGroup will lend to the project only assures the fidelity of the data collection activities.

We have the foundational technology to develop rapid and quantitative diagnostics tests for different biomarkers using Quantum Dots. The quantitative features as well as the accuracy levels of our tests make them ideal for immunity level detection, biomarker monitoring in drug development, infectious diseases management through population studies for predictive models, and  biomarkers trends monitoring for personal health.


We are developing a companion secured and encrypted data platform for our Quantum Dot diagnostics. Numerical data from test results will be organized and managed to allow people to monitor trends of biomarkers associated with their health concerns, anonymized positive or negative population data for infectious diseases management, and monitor biomarkers to accelerate drug development for pharmaceutical companies.


We are partnering with several companies who bring novel drug delivery systems that will benefit from our Quantum Dot diagnostics technology and our data platform to participate in population studies that we are spearheading to create predictive models for infectious diseases.  We are helping in the formulation of  new drugs with potential increases in the bioavailability of beneficial APIs while substantially reducing toxicity and side effects.